OPTIMARK

This brand name is authorized in Austria, Brazil, Estonia, Lithuania, South Africa.

Active ingredients

The drug OPTIMARK contains one active pharmaceutical ingredient (API):

1	Gadoversetamide UNII RLM74T3Z9D - GADOVERSETAMIDE
	Gadoversetamide is a chelate containing gadolinium – which has paramagnetic properties and is responsible for the contrast enhancement effect in MRI – and the ligand versetamide. Gadoversetamide after intravenous administration, equilibrates rapidly within the extracellular fluid/space and is eliminated primarily by glomerular filtration.
	Read more about Gadoversetamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OPTIMARK Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V08CA06	Gadoversetamide	V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	524500301157211, 524500302153218, 524500303151219, 524500304156214, 524500305152212, 524500306159210, 524500307155219
EE	Ravimiamet	1308046, 1308057, 1308068, 1308079, 1308080, 1308091, 1308103, 1308114, 1308125, 1308147, 1308158, 1308169, 1308170
LT	Valstybinė vaistų kontrolės tarnyba	1030322, 1030323, 1030324, 1030325, 1030326, 1030327, 1030328, 1030329, 1030330, 1030331, 1030332, 1030333, 1030334, 1030335
ZA	Health Products Regulatory Authority	42/28/0102, 42/28/0103, 42/28/0104, 42/28/0105